Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxybutynin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 6/20 | 0.98 |
| ▸ | CHRM3 known ✓ | P20309 | 4/20 | 0.98 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.98 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.98 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.98 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.98 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.98 |
| ▸ | PKM | P14618 | 1/20 | 0.98 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.98 |
| ▸ | THPO | P40225 | 1/20 | 0.98 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxybutynin SCHEMBL5494388 | 1.00 | MEN1 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Esoxybutynin SCHEMBL5690091 | 1.00 | MEN1 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Aroxybutynin SCHEMBL27093068 | 1.00 | MEN1 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL8019436 | 1.00 | MEN1 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL1560964 | 0.99 | CHRM2 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Esoxybutynin SCHEMBL290373 | 0.99 | CHRM2 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL2992 | 0.99 | CHRM2 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Aroxybutynin SCHEMBL25880 | 0.99 | CHRM2 (1.00) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL7557853 | 0.98 | CHRM2 (0.98) | MEN1RECQLPMP22KMT2ANPSR1 | |
| Oxybutynin SCHEMBL7895841 | 0.98 | CHRM2 (0.98) | MEN1RECQLPMP22KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6806 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3659594-B2 | A STERILE SOLUTION WITH AN APPLICATION INJECTOR COMPRISING A MEDICAL AGENT AND METHOD FOR PRODUCING SAME | STEGEMANN KLAUS (DE) | 2026-04-29 | — | — | EP | claimed |
| US-20260076872-A1 | POLYMER VIALS WITH SUBSTANTIALLY FLAT BOTTOMS AND INJECTION STRETCH BLOW MOLDING METHODS FOR MAKING THE SAME | SIO2 MEDICAL PRODUCTS LLC (US) | 2026-03-19 | — | — | US | claimed |
| US-20250271426-A1 | REDUCTION OF BITTER TASTE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND RELATED ASSAYS AND SCREENING METHODS | FIRMENICH INCORPORATED (US) | 2025-08-28 | — | — | US | claimed |
| US-20250242092-A1 | SiOx BARRIER FOR PHARMACEUTICAL PACKAGE AND COATING PROCESS | SIO2 MEDICAL PRODUCTS INC (US) | 2025-07-31 | — | — | US | claimed |
| US-12257371-B2 | SiOx barrier for pharmaceutical package and coating process | SIO2 MEDICAL PRODUCTS, LLC (US) | 2025-03-25 | — | — | US | claimed |
| CN-119486719-A | Osmotic pump controlled release preparation, osmotic pump controlled release composition, preparation method and application | 中国科学院上海药物研究所 | 2025-02-18 | — | — | CN | claimed |
| US-20250032503-A1 | USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE | HOTH THERAPEUTICS, INC. | 2025-01-30 | — | — | US | claimed |
| EP-4493928-A1 | REDUCTION OF BITTER TASTE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND RELATED ASSAYS AND SCREENING METHODS | Firmenich Incorporated (US) | 2025-01-22 | — | — | EP | claimed |
| US-20240390364-A1 | Novel Pyridine Compositions and their use in methods for preventing or treating diseases, disorders and conditions | REID CHRISTOPHER BRIAN (US) | 2024-11-28 | — | — | US | claimed |
| EP-3357945-B1 | ADHESIVE POLYMER AND MEDICAL ADHESIVE PATCH | TEIKOKU SEIYAKU KK (JP) | 2024-10-30 | — | — | EP | claimed |
| US-5700410-A | Method of manufacturing wax matrices | NIPPON SHINYAKU CO., LTD. (JP) | 1997-12-23 | — | — | US | claimed |
| EP-0580860-B1 | METHOD OF MANUFACTURING SOLID DISPERSION | NIPPON SHINYAKU CO LTD (JP) | 1997-10-22 | — | — | EP | claimed |
| EP-0800384-A1 | PHARMACEUTICAL TABLET FORMULATIONS FOR DIRECT COMPRESSION | ENBALT TRADING LIMITED (IE) | 1997-10-15 | — | — | EP | claimed |
| US-5629008-A | Method and device for long-term delivery of drugs | C.R. BARD, INC. (US) | 1997-05-13 | — | — | US | claimed |
| EP-0759750-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO, Howard, K. (US) | 1997-03-05 | — | — | EP | claimed |
| WO-1996018386-A1 | PHARMACEUTICAL TABLET FORMULATIONS FOR DIRECT COMPRESSION | ENBALT TRADING LIMITED (IE) | 1996-06-20 | — | — | WO | claimed |
| WO-1996012477-A1 | CONTROLLED RELEASE ORAL DELIVERY SYSTEM CONTAINING OXYBUTYNIN | LEIRAS OY (FI) | 1996-05-02 | — | — | WO | claimed |
| WO-1995033511-A1 | METHOD AND DEVICE FOR LONG-TERM DELIVERY OF DRUGS | C.R. BARD, INC. (US) | 1995-12-14 | — | — | WO | claimed |
| WO-1995031194-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1995-11-23 | — | — | WO | claimed |
| EP-0572932-A2 | Method and implant device for long term delivery of drugs | C.R. BARD, INC. (US) | 1993-12-08 | — | — | EP | claimed |